Clinical Trials Browser

Phase 2 × sagopilone × Gynecologic × Clear all

NCT00246688 2015-12-31

Efficacy and Safety Study of ZK219477 in Patients With Recurrent Ovarian Cancer

Phase 2 Completed

Ovarian Neoplasms

NCT00751205 2014-10-28

Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC)

Phase 2 Completed

GenitourinaryGynecologic

Ovarian Neoplasms, Peripheral Nervous System Diseases, Prostatic Neoplasms